Open an account Help & support Register Account summary Log out
Skip Header
Home Stock market news

Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

ECO Animal Health shares surge on poultry drug milestone

Mon 10 Nov 2025 10:43

(Sharecast News) - The share price of ECO Animal Health surged on Monday after European regulators recommended marketing authorisation for its poultry vaccine ECOVAXXIN MS.

The AIM-listed company, which focuses on treatments for respiratory and enteric diseases in pigs and poultry, said the key milestone now establishes a roadmap for the commercial launch of the drug in the second half of 2026.

ECOVAXXIN MS is an immunisation against mycoplasma synoviae, which can cause air-sac and foot-pad lesions in poultry, which can result in a 5-10% reduction in the number of eggs laid by affected hens.

David Hallas, chief executive of ECO Animal Health, said he was "delighted" by the announcement from the the Committee for Medicinal Products for Veterinary Use of the European Medicines Agency.

"This marks an exciting time for the company, with further submissions expected over the next 12 months for additional products from our R&D pipeline, underpinning ECO's next phase of growth."

The stock was up 8.4% at 87.8p by 1136 GMT.

Share this article

Related Sharecast Articles

Wed 14 Oct 2026 12:08
Thursday preview: TSMC results, UK GDP in focus
(Sharecast News) - Thursday will see the release of a first-quarter trading update from homeware retailer Dunelm and UK GDP data.
Wed 14 Oct 2026 11:30
Jefferies upgrades Pennon to 'buy'
(Sharecast News) - Jefferies upgraded Pennon to 'buy' from 'hold' on Wednesday but cut the price target to 380p from 500p.
Wed 14 Oct 2026 10:11
Berenberg lowers target price on Oxford Instruments
(Sharecast News) - Analysts at Berenberg lowered their target price on Oxford Instruments to 2,840p from 3,000p, noting the recent strength in order intake now looks largely priced in.
Wed 14 Oct 2026 10:10
Great Portland Estates secures £19m of lettings
(Sharecast News) - Property development and investment firm Great Portland Estates said on Wednesday that it had secured £19m of lettings in the first half, with deals struck 4.1% ahead of enterprise rental value.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Awards

Award 1
Award 2
Award 3

Policies and important information

Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statements | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Statutory and Regulatory disclosures | Whistleblowing programme

Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document or Product Summary document which contains important information about the fund.

This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.

© FIL Limited 2026